k
Earnings Beat: Pepsi, Toyota, AstraZeneca, Unilever and More
@Tiger_Newspress:Here are the companies that released better-than-expected quarterly earnings reports before the U.S. market opens on Thursday: PepsiCo Q4 Earnings Beat Estimates As Guidance Falls Short; Board Approves 10% Dividend Hike PepsiCo Inc. had a net income of $518 million, or 37 cents a share, in the fourth quarter, down from $1.322 billion, or 95 cents a share, in the year-earlier period. Adjusted for non-recurring items, the company had an EPS of $1.67, ahead of the $1.65 FactSet consensus. Revenue rose to $27.996 billion from $25.248 billion a year ago, also ahead of the FactSet consensus of $26.828 billion. The company is now expecting 2023 adjusted EPS of $7.20, below the FactSet consensus of $7.27. The board approved a 10% increase in its annualized dividend to $5.06 a share from $4.60 previously. Toyota's Q3 Profit Jumps 22% As Weak Yen Helps Toyota Motor Corp on Thursday posted a surprise 22% rise in third-quarter operating profit, as a weaker yen and higher sales volumes helped the Japanese automaker overcome a jolt from soaring raw-materials costs. Operating profit for the three months ended Dec. 31 was 956.7 billion yen ($7.28 billion). That beat the average 764.54 billion yen profit estimated by 10 analysts, according to Refinitiv data. In the same period a year earlier, Toyota reported a 784.4 billion yen profit. While it trimmed its annual production target by about 1%, to around 9.1 million vehicles, it stuck to its forecast for an annual profit of 2.4 trillion yen for the year to end-March. AstraZeneca Reports Profit Beat, Sees Growth Amid New Drug Launches AstraZeneca Plc reported better-than-expected profit and said earnings will rise this year, helped by demand for drugs like Farxiga for diabetes and Tagrisso for cancer. Earnings per share were $1.38 in the fourth quarter, beating the average analyst estimate of $1.35. Revenue from Covid-19 medicines will probably decline significantly this year. Unilever Beats Fourth-Quarter Sales Estimates Unilever Plc on Thursday reported quarterly underlying sales growth above expectations, helped by higher prices for its detergents, soaps and packaged food. It expects cost inflation to continue in 2023, forecasting net material inflation in the first half of around 1.5 billion euros. Underlying sales rose 9.2% in the fourth quarter, beating company-provided analyst estimates of an 8.2% increase. ASE Technology GAAP EPADS of $0.228 Beats By $0.02, With Revenue of NT$177.42B Its Q4 GAAP EPADS was $0.228 beats by $0.02, revenue was NT$177.42B (+2.6% Y/Y), and gross margin decreased by 0.9 percentage points to 19.2% in 4Q22 from 20.1% in 3Q22, operating margin was 11.1% in 4Q22, compared to 12.6% in 3Q22, current ratio was 1.35 and net debt to equity ratio was 0.43 as of December 31, 2022, capital expenditures in 4Q22 totaled $339M. $(PEP)$ $(TM)$ $(AZN)$ $(UL)$ $(ASX)$
Earnings Beat: Pepsi, Toyota, AstraZeneca, Unilever and MoreDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.